Skip to main content
Log in

A p-methoxybenzyl (PMB) protection/deprotection approach toward the synthesis of 5-phenoxy-4-chloro-N-(aryl/alkyl) thiophene-2-sulfonamides

  • Full-Length Paper
  • Published:
Molecular Diversity Aims and scope Submit manuscript

Abstract

The synthesis of 17 phenoxy substituted 4-chloro-N-(aryl/alkyl)thiophene-2-sulfonamides using a PMB protection/deprotection strategy is described. Nucleophilic displacement of p-methoxybenzyl (PMB) protected 4,5-dichloro-N-(aryl/alkyl)-thiophene-2-sulfonamides was carried out with different phenols under mild basic conditions. Reaction times of 3–6 h and overall yields of 78–98% were achieved with the PMB group in place compared to no reaction without this protecting group. The PMB group was easily and selectively removed in 68–98% yield using TFA in DCM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cole AG, Metzger A, Brescia MR, Qin LY, Appell KC, Brain CT, Hallett A, Ganju P, Denholm AA, Wareing JR, Ritchie TJ, Drake GM, Bevan SJ, MacGloinn A, McBryde A, Patel V, Oakley PJ, Nunez X, Gstach H, Schneider P, Baldwin JJ, Dolle RE, McDonald E, Henderson I (2009) Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists. Bioorg Med Chem Lett 19: 119–122. doi:10.1016/j.bmcl.2008.11.005

    Article  CAS  PubMed  Google Scholar 

  2. Kumar YCS, Malviya M, Chandra JNNS, Sadashiva CT, Kumar CSA, Prasad SBB, Prasanna DS, Subhas MN, Rangapp KS (2008) Effect of novel N-aryl sulfonamide substituted 3-morpholinoarecoline derivatives as muscarinic receptor 1 agonists in Alzheimer’s dementia models. Bioorg Med Chem 16: 5157–5163. doi:10.1016/j.bmc.2008.03.019

    Article  PubMed  Google Scholar 

  3. Ganesh T, Thepchatri P, Li L, Du Y, Fu H, Snyder JP, Sun A (2008) Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicro-molaractivity in an in vitro assay. Bioorg Med Chem Lett 18: 4982–4987. doi:10.1016/j.bmcl.2008.08.022

    Article  CAS  PubMed  Google Scholar 

  4. Wang GT, Mantei RA, Kawai M, Tedrow JS, Barnes DM, Wang J, Zhang Q, Lou P, Garcia LA, Bouska J, Yates M, Park C, Judge RA, Lesniewski R, Sheppard GS, Bell RL (2007) Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids. Bioorg Med Chem Lett 17: 2817–2822. doi:10.1016/j.bmcl.2007.02.062

    Article  CAS  PubMed  Google Scholar 

  5. Mader MM, Shih C, Considine E, Dios AD, Grossman CS, Hipskind PA, Shen H-L, Lobb KL, Lopez B, Lopez JE, Cabrejas LMM, Richett ME, White WT, Cheung Y-Y, Huang Z, Reilly JE, Dinn SR (2007) Acyl sulfonamide anti-proliferatives. Part 2: activity of heterocyclic sulfonamide derivatives. Bioorg Med Chem Lett 15: 617–620. doi:10.1016/j.bmcl.2004.11.041

    Article  Google Scholar 

  6. Caldirola P, Jossan S, Sakariassen KS, Svartengren J (2002) Aryl sulfonamides as serotonin antagonists for the treatment of obesity. WO 2002008179 A1

  7. Ruckle T, Biamonte M, Grippi-Vallotton T, Arkinstall S, Cambet Y, Camps M, Chabert C, Church DJ, Halazy S, Jiang X, Martinou I, Nichols A, Sauer W, Gotteland J-P (2004) Design, synthesis, and biological activity of novel, potent, and selective (benzoylaminomethyl)thiophene sulfonamide inhibitors of c-Jun-N-terminal kinase. J Med Chem 47: 6921–6934. doi:10.1021/jm031112e

    Article  PubMed  Google Scholar 

  8. Grundner C, Perrin D, Van Huijsduijnen RH, Swinnen D, Gonzalez J, Gee CL, Wells TN, Alber T (2007) Structural basis for selective inhibition of Mycobacterium tuberculosis protein tyrosine phosphatase PtpB. Structure 15: 499–509. doi:10.1016/j.str.2007.03.003

    Article  CAS  PubMed  Google Scholar 

  9. Innocenti A, Villar R, Martinez-Merino V, Gil MJ, Scozzafava A, Vullo D, Supuran CT (2005) Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with benzo[b]thiophene 1,1-dioxide sulfonamides. Bioorg Med Chem Lett 15: 4872–4876. doi:10.1016/j.bmcl.2005.04.078

    Article  CAS  PubMed  Google Scholar 

  10. Hu B, Ellingboe J, Han S, Largis E, Lim K, Malamas M, Mulvey R, Niu C, Oliphant A, Pelletier J, Singanallore T, Sum F-W, Tillett J, Wong V (2001) Novel (4-Piperidin-1-yl)-phenyl sulfonamides as potent and selective human β3 agonists. Bioorg Med Chem 9: 2045–2059. doi:10.1016/S0968-0896(01)00114-6

    Article  CAS  PubMed  Google Scholar 

  11. Wu C, Decker ER, Blok N, Li J, Bourgoyne AR, Bui H, Keller KM, Knowles V, Li W, Stavros FD, Holland GW, Brock TA, Dixon RA (2001) Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides: TBC3214, an ETA selective endothelin antagonist. J Med Chem 44: 1211–1216. doi:10.1021/jm000349x

    Article  CAS  PubMed  Google Scholar 

  12. Chen G, Wang H, Robinson H, Cai J, Wan Y, Ke H (2008) An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studies. Biochem Pharmacol 75: 1717–1728. doi:10.1016/j.bcp.2008.01.019

    Article  CAS  PubMed  Google Scholar 

  13. Gubler M, Haap W, Hebeisen P, Kitas EA, Kuhn B, Minder RE, Schott B, Wessel HP (2007) Preparation of sulfonylureido thiazoles as fructose-1,6-bisphosphatase (FBPase) inhibitors for the treatment of diabetes. WO 2007137962 A1

  14. Guile SD, Bantick JR, Cooper ME, Donald DK, Eyssade C, Ingall AH, Lewis RJ, Martin BP, Mohammed RT, Potter TJ, Reynolds RH, St-Gallay SA, Wright AD (2007) Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties. J Med Chem 50: 254–263. doi:10.1021/jm060995h

    Article  CAS  PubMed  Google Scholar 

  15. Morley JO, Matthews T (2006) Studies on the biological activity of some nitrothiophenes. Org Biomol Chem 4: 359–366. doi:10.1039/b514441h

    Article  CAS  PubMed  Google Scholar 

  16. Herpin TF, Morton GC, Rehfuss RP, Lawrence RM, Poss MA, Roberge JY, Gungor T (2005) Preparation of aminobenzazoles and analogs as P2Y1 receptor inhibitors for treating thromboembolic disorders. WO 2005070920 A1

  17. Binder D, Pyerin M, Pusterer F (1999) Synthesis of substituted alkoxythiophenes. Thiophene analogs of dazoxiben. Monatsh Chem 130: 645–651. doi:10.1007/PL00010245

    CAS  Google Scholar 

  18. Stanetty P, Puschautz E (1989) Herbicidal thienylureas. II. Monatsh Chem 120: 65–72. doi:10.1007/BF00809650

    Article  Google Scholar 

  19. Gilchrist TL (1992) Heterocyclic chemistry, 3rd edn. Addison Wesley, Essex, p 226 pp

    Google Scholar 

  20. Park C-M, Oie T, Petros AM, Zhang H, Nimmer PM, Henry RF, Elmore SW (2006) Design, synthesis, and computational studies of inhibitors of Bcl-X L . J Am Chem Soc 28: 16206–16212. doi:10.1021/ja0650347

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfred L. Williams.

Electronic Supplementary Material

The Below is the Electronic Supplementary Material.

ESM 1 (DOC 23.6 mb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, A.L., Dandepally, S.R. & Kotturi, S.V. A p-methoxybenzyl (PMB) protection/deprotection approach toward the synthesis of 5-phenoxy-4-chloro-N-(aryl/alkyl) thiophene-2-sulfonamides. Mol Divers 14, 697–707 (2010). https://doi.org/10.1007/s11030-009-9208-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11030-009-9208-y

Keywords

Navigation